ROC analysis showed that both SLC6A19 and the established CRC biomarker CEA had moderate diagnostic accuracy for distinguishing CRC from normal tissues, with CEA performing slightly better (AUC = 0.829 vs. 0.789) in the READ cohort (Figure 6C). The gene discussed is SLC6A19; the disease is colorectal carcinoma.